News & Updates
Filter by Specialty:
RSV vaccine plus flu or COVID-19 shots safe, feasible in older adults
Coadministration of mRNA-1345, a respiratory syncytial virus (RSV) vaccine, with an influenza (flu) or a COVID-19 vaccine in older adults exhibits good tolerability and has an acceptable reactogenicity profile, according to a US study presented at ESCMID Global Congress 2024.
RSV vaccine plus flu or COVID-19 shots safe, feasible in older adults
13 May 2024
Dequalinium chloride works as well as metronidazole for bacterial vaginosis
In the treatment of bacterial vaginosis, dequalinium chloride is noninferior to metronidazole, with similarly high cure rates but better tolerability and fewer adverse events, according to a phase IV study.
Dequalinium chloride works as well as metronidazole for bacterial vaginosis
10 May 2024
Vonoprazan-amoxicillin on par with quadruple therapy for H pylori eradication
Dual therapy with vonoprazan and amoxicillin (VA-dual) for 10 days results in a 90.8-percent eradication rate of Helicobacter pylori (H pylori) and fewer adverse events (AEs) compared with the standard 14-day bismuth-based quadruple therapy (B-quadruple), a study has shown.
Vonoprazan-amoxicillin on par with quadruple therapy for H pylori eradication
09 May 2024
Speeding COVID-19 symptom recovery may not fall within the realm of nirmatrelvir–ritonavir
Treating COVID-19 patients who had been vaccinated or did not have risk factors for severe disease with ritonavir-boosted nirmatrelvir (nirmatrelvir–ritonavir) did not expedite the time to symptom alleviation, reported investigators in the EPIC-SR trial.